Relafen vs. Voltaren

Are Relafen and Voltaren the Same Thing?

Relafen(nabumetone) andVoltaren(diclofenac) are nonsteroidalanti-inflammatory drugs (NSAIDs) used to treatinflammationandpaincaused byarthritis.

Voltaren is also used to treatankylosing spondylitis.

The brand names Relafen and Voltaren are no longer availableinthe U.S.Genericversions may be available.

Side effectsRelafen和Voltaren类似的公司lude upsetstomach,heartburn, stomach pain,diarrhea,constipation, bloating, gas,dizziness,headache, nervousness,skinitchingorrash,blurred vision, or ringing in your ears.

Side effects of Voltaren that are different from Relafen include ulcers.

Both Relafen and Voltaren may interact withalcohol,antidepressants,bloodthinners,lithium,methotrexate,heartorblood pressuremedications,diuretics(waterpills), steroids, andaspirinor other NSAIDs.

Relafen may also interact withACE inhibitors.

Voltaren may also interact withcyclosporine,isoniazid, pronbenecid,rifampin, secobarbital,sertraline, sulfamethoxazole, teniposide, zafirlukast, antifungals, andcholesterol-lowering medicines.

What Are Possible Side Effects of Relafen?

Common side effects of Relafen include:

  • upset stomach,
  • heartburn,
  • stomach pain,
  • diarrhea,
  • constipation,
  • bloating,
  • gas,
  • dizziness,
  • headache,
  • nervousness,
  • skin itching or rash,
  • blurred vision, or
  • ringing in your ears.

Nonsteroidal anti-inflammatory drugs (including Relafen) may rarely increase the risk for aheart attackorstroke. Bleeding from thegastrointestinal tractis another potentially serious side effect of Relafen.

What Are Possible Side Effects of Voltaren?

Common side effects of Voltaren include:

  • nausea,
  • stomach pain,
  • upset stomach,
  • diarrhea,
  • gas,
  • ulcers, or
  • itching,
  • dryness,
  • redness,
  • scaling,
  • numbness and tingling,
  • cysts,
  • pimples, or other
  • skin irritation where the medicine was applied.

What Is Relafen?

Relafen (nabumetone) is a nonsteroidal anti-inflammatory (NSAID) drug used to treat inflammation and pain caused by arthritis. The brand name drug Relafen is no longer available in the U.S. Generic versions may be available.

What Is Voltaren?

Voltaren Gel(diclofenacsodiumtopicalgel) is a topical gel nonsteroidal anti-inflammatory drug (NSAID) used to treat pain ofosteoarthritisof joints that are amenable to topical treatment, such the hands and knees.

What Drugs Interact With Relafen?

Relafen may interact with antidepressants, blood thinners, lithium, methotrexate, diuretics (water pills), steroids, aspirin or other NSAIDs, or ACE inhibitors.. There are no adequate, well-controlled studies inpregnantwomen, and Relafen should be used inpregnancyonly if the potential benefit justifies the potential risk to thefetus. Use during late pregnancy should be avoided because of the known effects of NSAIDs in the fetalcardiovascular system(closure ofductus arteriosus). It is not known whether Relafen is excreted in human milk; a decision should be made whether to discontinuebreastfeedingor to discontinue the Relafen.

What Drugs Interact With Voltaren?

Voltaren凝胶可能与阿司匹林,锂,diuretics (water pills), blood thinners, and methotrexate.

Voltaren Gel may also interact with heart or blood pressure medications, cyclosporine, steroids, certain antibiotics, and other topical treatments.

How Should Relafen Be Taken?

Use the lowesteffective dosefor the shortest duration consistent with individualpatienttreatment goals.

How Should Voltaren Be Taken?

The proper amount of Voltaren® Gel should be measured using the dosing card supplied in the drug product carton. The dosing card is made of clear polypropylene. The dosing card should be used for each application of drug product. The gel should be applied within the rectangular area of the dosing card up to the 2gramor 4 gram line (2 g for each,wrist, or hand, and 4 g for eachknee,ankle, orfoot). The 2 g line is 2.25 inches long. The 4 g line is 4.5 inches long. The dosing card containing Voltaren® Gel can be used to apply the gel. The hands should then be used to gently rub the gel into the skin. After using the dosing card, hold with fingertips, rinse, and dry. If treatment site is the hands, patients should wait at least one (1) hour to wash their hands.

Lower Extremities, Including The Feet, Ankles, Or Knees

Apply the gel (4 g) to the affected foot, ankle, or knee 4 times daily. Voltaren® Gel should be gently massaged into the skin ensuring application to the entire affected foot, or knee or ankle. The entire foot includes the sole, top of the foot and the toes. Do not apply more than 16 g daily to any singlejointof the lower extremities.

Upper Extremities Including The Hands, Wrists, Or Elbows

Apply the gel (2 g) to the affected hand, wrist, or elbow 4 times daily. Voltaren® Gel should be gently massaged into the skin ensuring application to the entire affected hand, wrist, or elbow. The entire hand includes thepalm, back of the hands, and the fingers. Do not apply more than 8 g daily to any single joint of the upper extremities.

Total dose should not exceed 32 g per day, over all affected joints.

Special Precautions

  • Avoid showering/bathing for at least 1 hour after the application. Inform patient to washhis/她的手用后,除非手中大树下面ated joint. If Voltaren® Gel is applied to the hand(s) for treatment; inform patient not to wash the treated hand(s) for at least 1 hour after the application.
  • Do not apply Voltaren® Gel to open wounds.
  • Avoid contact of Voltaren® Gel with eyes andmucousmembranes.
  • Do not apply external heat and/or occlusive dressings to treated joints.
  • Avoid exposure of the treated joint(s) to natural or artificial sunlight.
  • Avoid concomitant use of Voltaren® Gel on the treated skin site with other topical products, including sunscreens, cosmetics, lotions, moisturizers, insect repellants, or other topical medications
  • Concomitant use of Voltaren® Gel withoralnon-steroidal anti-inflammatory drugs(NSAIDs) has not been evaluated, and may increase adverse NSAIDs effects. Do not use combinationtherapywith Voltaren® Gel and an oral NSAID unless the benefit outweighs the risk and conduct periodiclaboratoryevaluations.
  • Avoid wearing of clothing or gloves for at least 10 minutes after applying Voltaren® Gel.
Disclaimer

All drug information provided on RxList.com is sourced directly from drug monographs published by the U.S. Food and Drug Administration (FDA).

Any drug information published on RxList.com regarding general drug information, drug side effects, drug usage, dosage, and more are sourced from the original drug documentation found in its FDA drug monograph.

Drug information found in the drug comparisons published on RxList.com is primarily sourced from the FDA drug information. The drug comparison information found in this article does not contain any data from clinical trials with human participants or animals performed by any of the drug manufacturers comparing the drugs.

The drug comparisons information provided does not cover every potential use, warning, drug interaction, side effect, or adverse or allergic reaction. RxList.com assumes no responsibility for any healthcare administered to a person based on the information found on this site.

As drug information can and will change at any time, RxList.com makes every effort to update its drug information. Due to the time-sensitive nature of drug information, RxList.com makes no guarantees that the information provided is the most current.

Any missing drug warnings or information does not in any way guarantee the safety, effectiveness, or the lack of adverse effects of any drug. The drug information provided is intended for reference only and should not be used as a substitute for medical advice.

If you have specific questions regarding a drug’s safety, side effects, usage, warnings, etc., you should contact your doctor or pharmacist, or refer to the individual drug monograph details found on the FDA.gov or RxList.com websites for more information.

You may also report negative side effects of prescription drugs to the FDA by visiting the FDA MedWatch website or calling 1-800-FDA-1088.

References
SOURCE:

FDA. Relafen Product Information.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/019583s023lbl.pdf

DailyMed. Voltaren Product Information.

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=60045fc6-f0d9-4f67-ba91-c3b317596437

Health SolutionsFrom Our Sponsors